Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Grouven

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Der Anaesthesist|February 4, 2010
[EEG-adjusted target-controlled infusion : Propofol target concentration with different doses of remifentanil]N Büttner, B Schultz, U Grouven, et al.
Computers in Biology and Medicine|July 1, 1995
A PC program for unbiased and predictive linear and quadratic discriminant analysisU Grouven, F Bergel, B Schultz, et al.
Anaesthesia and Intensive Care|May 2, 2000
Epileptiform activity in the EEGs of two nonepileptic children under sevoflurane anaesthesiaA Schultz, B Schultz, U Grouven, et al.
Die Rehabilitation|November 24, 2006
[Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research]M Kutschmann, R Bender, U Grouven, et al.
Methods of Information in Medicine|September 1, 1992
Application of adjusted survival curves to renal transplant dataU Grouven, R Bender, A Schultz, et al.
Deutsche Medizinische Wochenschrift (1946)|May 29, 2007
[Comparing methods of measurement]U Grouven, R Bender, A Ziegler, et al.
Biomedizinische Technik. Biomedical Engineering|April 27, 2004
The Narcotrend Index: classification algorithm, correlation with propofol effect-site concentrations, and comparison with spectral parametersA Schultz, U Grouven, F A Beger, et al.
The Clinical Investigator|August 1, 1993
Kidney transplantation from cadaveric donors versus living related donors: improved results in the cyclosporine eraU Grouven, A Safer, U Frei, et al.
Diabetologia|January 26, 2010
Insufficient evaluation of adverse events is not a proof of safetyL G Hemkens, U Grouven, R Bender, et al.
Diabetologia|October 27, 2009
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]U Grouven, L G Hemkens, R Bender, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Der Anaesthesist|February 4, 2010
[EEG-adjusted target-controlled infusion : Propofol target concentration with different doses of remifentanil]N Büttner, B Schultz, U Grouven, et al.
Computers in Biology and Medicine|July 1, 1995
A PC program for unbiased and predictive linear and quadratic discriminant analysisU Grouven, F Bergel, B Schultz, et al.
Anaesthesia and Intensive Care|May 2, 2000
Epileptiform activity in the EEGs of two nonepileptic children under sevoflurane anaesthesiaA Schultz, B Schultz, U Grouven, et al.
Die Rehabilitation|November 24, 2006
[Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research]M Kutschmann, R Bender, U Grouven, et al.
Methods of Information in Medicine|September 1, 1992
Application of adjusted survival curves to renal transplant dataU Grouven, R Bender, A Schultz, et al.
Deutsche Medizinische Wochenschrift (1946)|May 29, 2007
[Comparing methods of measurement]U Grouven, R Bender, A Ziegler, et al.
Biomedizinische Technik. Biomedical Engineering|April 27, 2004
The Narcotrend Index: classification algorithm, correlation with propofol effect-site concentrations, and comparison with spectral parametersA Schultz, U Grouven, F A Beger, et al.
The Clinical Investigator|August 1, 1993
Kidney transplantation from cadaveric donors versus living related donors: improved results in the cyclosporine eraU Grouven, A Safer, U Frei, et al.
Diabetologia|January 26, 2010
Insufficient evaluation of adverse events is not a proof of safetyL G Hemkens, U Grouven, R Bender, et al.
Diabetologia|October 27, 2009
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]U Grouven, L G Hemkens, R Bender, et al.
Pageof 4